Global Anti-Snoring Devices and Snoring Surgery Market - 2022-2029

Global Anti-Snoring Devices and Snoring Surgery Market - 2022-2029

Market Overview

The global anti-snoring devices and snoring surgery market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Anti-snoring treatment devices, which include mandibular advancement devices (MAD), tongue stabilizing devices (TSD), continuous positive airway pressure (CPAP) devices, and nasal devices, among others, are characterized as equipment used to prevent snoring. The sound of resistance and turbulence in the upper airway is called snoring. Contrary to popular perception, snoring does not begin in the nose; instead, it begins in the back of the airway. During sleep, the oropharynx can become restricted behind the tongue. The upper airway muscles maintain the airway open when the patient relaxes during sleep. When muscles are most relaxed, this is particularly noticeable during REM sleep or dream sleep. Air turbulence develops when the airway narrows.

Market Dynamics

The market will expand due to an increasing geriatric population and rising demand for snore-controlling equipment. The weight around the neck area increases with age and narrows in size. Additionally, as people age, their sleeping habits alter, resulting in snoring.

Increased obesity and geriatric population will drive the market growth

Increased obesity and geriatric population, excessive smoking and alcohol use, technological developments in Anti-Snoring Devices and Snoring Surgery , and increased public awareness contribute to the market's rise. Because variations in weight gain impact the aged population, weight gain is a key contributor to the habit of snoring. Obesity is anticipated to reach peak levels in males between 2030 and 2052, and in women between 2026 and 2054, according to a study titled Obesity Prevalence in the Long-Term Future in 18 European Countries and the United States, published in October 2020. These maximum levels are most likely to be reached first by the Netherlands, the United States, the United Kingdom, and Switzerland. As a result, the market is likely to develop faster over the forecast period due to the increased prevalence of obesity among individuals. Furthermore, the growing geriatric population is likely to impact market growth significantly. According to the World Ageing Population report, around 702.9 million individuals aged 65 and more in 2019 will rise to 1,548.9 million by 2050. As a result of the cases mentioned above, the worldwide anti-snoring market is expected to develop due to an increasing geriatric population and obesity. While the number of people suffering from snoring is huge worldwide, the number of people choosing anti-snoring treatments is quite small. Around 40 million people in the United States suffer from snoring-related issues. However, only about 2% of those who choose to receive treatment do so. However, the anti-snoring devices market is growing due to increased awareness of the negative effects of snoring, the availability of anti-snoring treatments, and technological developments in anti-snoring goods. The presence of a huge untreated population, combined with growing countries and undeveloped markets, would help the market grow tremendously, providing expansion and growth potential in the anti-snoring devices and snoring surgery market.

High cost of procedures is likely to hamper the market growth

The high cost of procedures, the limited effectiveness of current treatments for this ailment, and negative reimbursement concerns may hamper the anti-snoring market's growth. Furthermore, the disadvantages of non-surgical devices, such as dry mouth, jaw discomfort, and excessive salivation, operate as significant barriers to patient utilization. Moreover, lack of reimbursement are important factors limiting the growth of the Anti-snoring Devices and Snoring Surgery Market.

COVID-19 Impact Analysis

In Wuhan, China, the global pandemic SARS-COV-2 was discovered. The World Health Organization declared the pandemic to be the emergence of healthcare. The supply chain for anti-snoring devices was cut in the first quarter of 2020. According to current studies, the supply chain for anti-snoring devices originates in CHINA; it is believed that 75 percent of the business is harmed; on the other hand, there are 51000 enterprises with direct or Tier Suppliers from the afflicted region globally. Due to the COVID-19 rules, the manufacturing of anti-snoring devices had to be postponed in part due to the lockdown and limited availability of resources and labor. The second half of 2020 has had a big impact on market growth. The global supply chain for anti-snoring devices has grown. To fulfill the demands, companies in this industry have improved their production capacity to make more gadgets. Advanced devices are being brought to the market, which is likely to grow over the forecast period.

Segment Analysis

The continuous positive airway pressure devices segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Based on devices, it is bifurcated into mandibular advancement devices,tongue stabilizing devices, continuous positive airway pressure devices and Others. The continuous positive airway pressure devices segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period. The continuous positive airway pressure (CPAP) devices sub-segment is believed to have the greatest market size in the Anti-Snoring Devices and Snoring Surgery segment. During this pandemic, demand for CPAP machines and masks is projected to surge, as CPAP devices have been demonstrated to help manage COVID-19 symptoms such as breathing difficulty. CPAP was reported to be a potential strategy in treating early-stage COVID-19 patients in a study titled CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation published in 2020. Airway obstructions are treated using continuous positive airway pressure (CPAP) devices, which pump air into the blocked airways. The CPAP has a pump that regulates the air pressure in the system and a tube that transports air to the mask worn over the nose and mouth. CPAP machines aid in the proper functioning of the airway and assist the user in getting a good night's sleep, raising their demand.

The corporations are continually developing CPAP products through product innovation, mergers, acquisitions, and other means to expand their market position. The market is predicted to grow faster as a result of this. For example, CPAP Store USA, one of the pioneers in CPAP equipment, launched its own CPAP Store USA brand in September 2020. It will be a retail store selling CPAP wipes, CPAP tubing, CPAP Filters, Chinstraps, CPAP machine travel bags and backpacks, and other supplies.

InnAccel launched SAANS, a CPAP solution, on the market in June 2019. It's the world's first infrastructure-free, portable, and neonatal CPAP technology that keeps the airway open and prevents it from collapsing. It also eliminates the tissue vibrations that induce snoring. As a result, CPAP devices are likely to rise during the forecast period.

Geographical Analysis

North America region holds the largest market share of the global anti-snoring devices and snoring surgery market

North America now dominates the anti-snoring devices and snoring surgery market, and this dominance is projected to last for a few more years. The introduction of COVID-19 is projected to impact the market positively. Sleep apnea was found as one of the risk factors among COVID-19 patients in a study published in the American Journal of Respiratory and Critical Care Medicine in 2020. Because snoring is typically connected with sleep apnea, these investigations point to the necessity for anti-snoring equipment among these individuals.

According to Sleep Foundation data, in the United States in 2019, approximately 57 percent of men and 40 percent of women had snoring problems. Furthermore, the growing obese and elderly populations are expected to fuel the market under consideration. According to the Centers for Disease Control and Prevention, the obesity rate in the United States is approximately 42.4 percent in 2019, a 26 percent increase since 2008. As a result, the growing patient population boosts the regional market growth.

However, thanks to new market technologies that are constantly being developed, the diagnosis of these snoring diseases have been effective, and treatments are proving to be more beneficial to patients. Thus, rising patient awareness of the effectiveness of anti-snoring devices and snoring surgery and the widespread availability of advanced detection procedures are driving up demand for anti-snoring devices and snoring and surgeries.

Competitive Landscape

The anti-snoring devices and snoring surgery market are highly fragmented. In terms of market share, the market is currently dominated by a few significant competitors. On the other hand, mid-size to smaller enterprises are expanding their market presence by introducing new ingredients at lower prices, thanks to technology advancements and product innovation.

Some of the key players which are contributing to the growth of the market include Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, Resmed, ASF Medical GmbH, Apnea Sciences, MPowRX, Somnomed Ltd, Airway Management, Medtronic plc, Meditas among others.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the anti-snoring devices and snoring surgery market globally. For instance, In February 2021, The US Food and Drug Administration (US FDA) has approved the marketing of Rotech Healthcare's eXciteOSA, a prescription-only anti-snoring device. It uses a mouthpiece wrapped around the tongue to administer electrical muscle stimulation.

Apnea Sciences

Overview:

Apnea Sciences aims to improve society's health and well-being by developing breakthrough medical devices to treat and manage sleep disorders. We blend the latest research and innovation into patient-centered devices to deliver solutions for sleep-disordered breathing through improvements in diagnosis and therapy.

Product Portfolio:

SnoreRx: SnoreRx is the most advanced consumer snoring remedy, having become the first anti-snoring mouthguard approved by the FDA for over-the-counter use. SnoreRx is a snore-reduction device that keeps the lower jaw slightly forward during sleep to keep the airway open. Its exclusive Thermal MatrixTM design enhances retention and comfort.

Why Purchase the Report?

Visualize the composition of the global anti-snoring devices and snoring surgery market segmentation by devices type, surgery type, distribution channel ,end user, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global anti-snoring devices and snoring surgery market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global anti-snoring devices and snoring surgery market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global anti-snoring devices and snoring surgery market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 180-200 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers